I ACUITY- studiets arm B og C var den rekommanderede bivalirudindosis en initialt postrandomiseret IV bolus på 0, 1 mg/ kg legemsvægt efterfulgt af en kontinuerlig IV- infusion med 0, 25 mg/ kg legemsvægt/ time under angiografi eller som klinisk påkrævet.
In Arms B and C of the ACUITY trial, the recommended dose of bivalirudin was an initial post- randomisation IV bolus of 0.1mg/ kg followed by a continuous IV infusion of 0.25 mg/ kg/ h during angiography or as clinically warranted.